The results indicate that people in the study who received exenatide did not benefit compared to those who received placebo - suggesting that the drug does not slow down the progression of Parkinson’s.
We met with Neil Gray MSP, Cabinet Secretary for Health and Social Care, to discuss some of the challenges people with Parkinson's experience with the healthcare system in Scotland.
We're working with Table Tennis Scotland to make it possible for more people with Parkinson's to get and stay active through table tennis.
Following years of relentless campaigning by our community and charity, NHS England has committed to ensuring that time critical medication is delivered on time in hospitals as part of an exciting 3-year Medicines Safety Improvement Programme.
It's not just MPs who have been busy campaigning. Our local campaigners have been hard at work too. Here are some highlights of our work in England since the start of 2024.
Development of new Parkinson’s treatments is only possible if everyone is part of the research process. We need your help to push promising research forward.
A Lord’s inquiry supported by Parkinson’s UK has recommended the UK government urgently prioritises funding and support for clinical research.
From exciting research breakthroughs, to running marathons. We’re celebrating all of our community's fantastic achievements this year.
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
New research has been published that sheds an important light on how the production of a key protein in the brain is controlled This could pave the way for new treatments for a wide range of neurological conditions.
The earlier groundbreaking clinical trial proved inconclusive. So we’re launching a new company tasked with planning a possible new trial.